NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

beachhyena,

What is interesting is that this analysis is paid for by NWBO but the price expectation is tamped down by an absolute worst case scenario where big pharma, market makers and hedge funds control the price so that big pharma has a chance to offer a lowball price to investors. The problem arises for them with the 85% control they need to overcome board of director control and longs that support Linda’s vision won’t cave into that. This is not discussed at all. On the other hand there is less chance for negative feedback against these analysts for exaggeration of the expectations for price target being achievable. A 300%+ gain still looks pretty good and that is more important to gain interest from new investors vs appeasing existing investors; ). Best wishes.